4.7 Letter

Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply

Journal

CARDIOVASCULAR RESEARCH
Volume 113, Issue 11, Pages 1418-1419

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvx137

Keywords

-

Funding

  1. Bayer
  2. Servier

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available